Correlates of protection of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infections

Add to your list(s) Download to your calendar using vCal

• Elaine Shuo Feng ( University of Oxford)
• Friday 09 April 2021, 15:00-16:00
• Venue to be confirmed.

If you have a question about this talk, please contact Theodora Anderson.

For Zoom details please e-mail: pdgcambridge@gmail.com

: Understanding the relationship between immune response to SARS -CoV-2 vaccines and protection against clinical outcomes is urgently needed to facilitate further vaccine development. However, evidence on correlates of protection from SARS -CoV-2 vaccine trials is limited. Using phase II/III ChAdOx1 nCoV-19 vaccine trial data in the UK, we estimated the correlates of protection by immune markers against symptomatic COVID -19 disease using a case-cohort study design. Our preliminary analysis found higher immune marker levels are associated with lower risk of symptomatic disease and in particular lower risk of lower respiratory tract infections.

This talk is part of the PDG Seminars (Pathogen Dynamics Group) series.

This talk is included in these lists:

• PDG Seminars (Pathogen Dynamics Group)
• Venue to be confirmed
• se393's list

Note that ex-directory lists are not shown.